Parallax Volatility Advisers, L.P. Ptc Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $427,976 - $699,339	12,764 New	12,764 $487,000
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $224 - $315	-8 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $3,251 - $5,069	-109 Reduced 93.16%	8 $0
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $21.5 Million - $30.3 Million	-633,267 Reduced 99.98%	117 $5,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $9.59 Million - $13.2 Million	633,384	633,384 $10.6 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.